FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/04/2023
Voltar para busca
Dado oficial do USPTO
AXOLABS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
24/04/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
09/04/2021
Data de registro
20/12/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/12/2022
Última transação
20/12/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
DE
Examinador
CROWLEY, SEAN MICHAEL
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Axolabs GmbH
Representantes
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals and chemical products in the nature of industrial chemicals for use in industry, science and research; reagents for use in industry, science and research; biochemicals for use in industry, science and research; biological diagnostic preparations for research other than for medical use; chemical preparations for analysis or diagnosis used for scientific purposes; chemical preparations for use in the manufacture of pharmaceutical products, diagnostic preparations and substances; diagnostic assay preparations for scientific, industrial and research purposes; kits comprising assays and chemical reagents for industrial and scientific purposes; substances in the nature of industrial chemicals for analytical and biochemical science, genetic measurements, chemical diagnostics, forensic analysis, DNA/RNA testing and analytical molecular biology
Classe 5
diagnostic preparations for medical or veterinary purposes; reagents for medical or veterinary purposes; medical diagnostic reagents; test kits for diagnostic applications in the medical and veterinary field comprised of medical diagnostic reagents; medical substances for use in assay procedures being medical diagnostic reagents and assays for testing body fluids for microorganisms, presence or absence of endogenous and exogenous nucleic acids
Classe 42
Research and development services in the field of nucleic acid therapeutics; scientific research and industrial research in the field of oligonucleotide-based medicines and nucleic acid therapeutics; scientific laboratory services; biological research and analysis; biochemical research and analysis; chemical research and analysis; pharmaceutical research and development services; scientific consultancy in the field of nucleic acid therapeutics
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/04/2023
FIMP
FINAL DISPOSITION PROCESSED
05/04/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/04/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/03/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/01/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
20/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/10/2022
PUBO
PUBLISHED FOR OPPOSITION
04/10/2022
GPNX
NOTIFICATION PROCESSED BY IB
03/10/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/09/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
14/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/08/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
25/08/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/08/2022
GNFR
FINAL REFUSAL E-MAILED
04/08/2022
CNFR
FINAL REFUSAL WRITTEN
04/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/06/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/06/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/06/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
27/06/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/06/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/06/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/06/2022
RFNT
REFUSAL PROCESSED BY IB
15/01/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/12/2021
RFRR
REFUSAL PROCESSED BY MPU
27/12/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/12/2021
CNRT
NON-FINAL ACTION WRITTEN
30/11/2021
DOCK
ASSIGNED TO EXAMINER
30/11/2021
MAFR
APPLICATION FILING RECEIPT MAILED
09/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/11/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/10/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AXOLABS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.